{"title":"Erlotinib","summary":"Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer.[2] Specifically it is used for NSCLC with mutations in the epidermal growth factor receptor (EGFR) — either an exon 19 deletion (del19) or exon 21 (L858R) substitution mutation — which has spread to other parts of the body.[2] It is taken by mouth.[2]","image":"Erlotinib_Structural_Formulae.png.webp","url":"Erlotinib"}